Suzhou Womei Biotechnology Co., Ltd. (abbreviated as Womei Biotechnology) is one of China's one-stop solution service providers for biomedicine. Its products include customized culture media, bioreactors, immune adjuvants, biochemical reagents, etc. It is a core supplier in the upstream and downstream of bioprocessing, and also provides formula production, process optimization, process validation, technical support and supporting services for the biopharmaceutical industry. It is currently one of the high-tech comprehensive suppliers in the field of animal and pet vaccine manufacturing, and ranks among the top in the entire upstream field of biomedicine.
The founding team of Womei Biotechnology comes from outstanding graduates of the State Key Laboratory of Bioreactor Engineering (SKLBE) of East China University of Science and Technology, inheriting more than 30 years of technical accumulation and application experience of SKLBE in the fields of animal cell culture process engineering and bioreactor engineering. On the basis of this team's talent, the company has also attracted high-level talents from universities and foreign enterprises such as Shanghai Jiao Tong University, Fudan University, Sichuan Agricultural University, and Germany's Bosch. At present, the company has more than 200 employees, and its R&D and production levels are in line with international standards. Annual R&D investment is tens of millions of yuan.
In 2020, in order to promote the comprehensive upgrading of process development, quality system, management system and production capacity, Womei Biotechnology launched new factory construction projects for culture media, bioreactors and biochemical reagents in Zhangjiagang City, Suzhou and Qidong City, Nantong (Wotaishi Biotechnology), with a total area of 32,000 square meters. After completion, it will be able to achieve GMP standards, build a low-temperature pin milling powder process capacity of more than 100,000 liters per batch, and a total production capacity of more than 50 million liters. It will build a domestic industrial-grade bioreactor manufacturing base that can meet the production requirements of 3,000-20,000 liter bioreactors.
Relying on a strong R&D team, Womei Biotechnology has initially completed the layout of upstream and downstream process solutions for biopharmaceuticals. In the future, it will strive to build Womei Biotechnology into a comprehensive service provider that provides complete solutions in the domestic biopharmaceutical field. It will provide more high-quality technical services to Chinese antibody, vaccine, and cell therapy enterprises, and support innovative biopharmaceutical products such as antibodies, vaccines, and cell therapies in China to go global.
What does Suzhou Womei Biotechnology Co., Ltd. require? Who is Suzhou Womei Biotechnology Co., Ltd. hiring? recruitment: 贸易/物流/采购/运输类占比最多占22.2%,其次是销售类占20.4%. What education can get in at ? 本科占比最多占75.9%,其次是大专占18.5%. High education required at ? 硕士占3.7%. Work experience required at ? 不限占比最多占46.3%,其次是1-3年占25.9%. Where are the job locations at ? 苏州占比最多占74.1%,其次是上海占16.7%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows